MET and gastric cancer: Similarly, we recapitulated the known associations between amplifications of a chromosomal segment 7q31 including the MET oncogene, and sensitivity of esophageal/gastric cancer to crizotinib49,50 and also 3 other MET inhibitors (FDRs < 6%; Fig. 3E).